Gilteritinib
Back to searchScientific Name: | Gilteritinib |
Brand Name: | Xospata |
Company Owner: | Not Available |
Mechanism Of Action | Gilteritinib is a potent selective inhibitor of both of the mutations, internal tandem duplication (ITD) and tyrosine kinase domain (TKD) , of the FLT3 receptor. |
Description of the Drug: | Gilteritinib is an AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia. |
Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB12141